MONTELUKAST TEVA ® 5 MG

País: Israel

Língua: inglês

Origem: Ministry of Health

Ingredientes ativos:

MONTELUKAST AS SODIUM 5 MG

Disponível em:

SALOMON,LEVIN & ELSTEIN LTD

Código ATC:

R03DC03

Forma farmacêutica:

CHEWABLE TABLETS

Via de administração:

PER OS

Fabricado por:

TEVA OPERATIONS POLAND SP.ZO.O

Grupo terapêutico:

MONTELUKAST

Indicações terapêuticas:

Montelukast Teva is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 6 to 14 years of age and older.

Data de autorização:

2011-05-01